Diabetes mellitus, type 1 Trials in Helsinki, Finland
Conditions / Diabetes mellitus, type 1 / Helsinki, Finland
Diabetes mellitus, type 1 has been the subject of sustained clinical investigation across multiple research sites.
20 total trials for this combination
Showing top 10 of 20 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02098395 | The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT01836523 | The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT00095082 | Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT00435019 | Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT00365170 | Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes | COMPLETED | PHASE4 |
| NCT00474045 | Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT07222332 | A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE) | RECRUITING | — |
| NCT02580591 | Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3) | COMPLETED | PHASE3 |
| NCT02443155 | A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function | COMPLETED | PHASE2 |
| NCT01831765 | Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes | COMPLETED | PHASE3 |